IL6 and COVID-19: Although RIC has been shown to lower levels of IL-6, TNF-α, and IL-1β [15, 17] and improve survival in animal models of sepsis, whether this concept inspired by animal studies has an impact on inflammatory cytokines stimulated by COVID-19 has not been previously explored.